Article
Acetyl-CoA metabolism drives epigenome change and contributes to carcinogenesis risk in fatty liver disease
23 Jun 2022
Abstract excerpt
BACKGROUND: The incidence of non-alcoholic fatty liver disease (NAFLD)-associated hepatocellular carcinoma (HCC) is increasing worldwide, but the steps in precancerous hepatocytes which lead to HCC driver mutations are not well understood. Here we provide evidence that metabolically driven histone hyperacetylation in steatotic hepatocytes can increase DNA damage to initiate carcinogenesis. METHODS: Global...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
